Expression of HYAL1 and Survivin RNA as Diagnostic Molecular Markers for Bladder Cancer

Journal of Urology

Volumn 183, Issue 2, 2010, Pages 493-498

  Eissa, Sanaa ^a   Swellam, Menha ^d   Shehata, Hanan ^a   El Khouly, Inas M ^a   El Zayat, Tarek ^b   El Ahmady, Omar ^c  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

^d NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

biological; carcinoma; gene expression; tumor markers; urinary bladder; urine

Indexed keywords

HYALURONIDASE; HYALURONIDASE 1; RNA; SURVIVIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER CARCINOMA; CANCER DIAGNOSIS; CANCER STAGING; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHISTOSOMIASIS; SENSITIVITY AND SPECIFICITY; URINE CYTOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; EARLY DETECTION OF CANCER; HUMANS; HYALURONOGLUCOSAMINIDASE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; RNA; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 73749088623     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.10.024     Document Type: Article

References (24)

1. Irani J., Mottet N., Caparro M.J.R., et al. New trends in bladder cancer management. Eur Urol 53 (2007) 909
2. Golshani R., Hautmann S.H., Estrella V., et al. HAS1 expression in bladder cancer and its relation to urinary HA test. Int J Cancer 120 (2007) 1712
3. Posey J.T., Soloway M.S., Ekici S., et al. Evaluation of the Prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer1. Cancer Res 63 (2003) 2638
4. Lokeshwar V.B., Young M.J., Goudarzi G., et al. Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1. Cancer Res 59 (1999) 4464
5. Lepperdinger G., Strobl B., and Kreil G. HYAL2, a human gene expressed in many cells, encode a lysosomal hyaluronidase with a novel type of specificity. J Biol Chem 273 (1998) 22466
6. Vines C.A., Li M.W., Deng X., et al. Identification of a hyaluronic acid (HA) binding domain in the PH-20 protein that may function in cell signaling. Mol Reprod Dev 60 (2001) 542
7. Lokeshwar V.B., Bek C.N., Pham H.T., et al. Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade. J Urol 163 (2000) 348
8. Eissa S., Kassim S.K., Labib R.A., et al. Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs. Cancer 103 (2005) 1356
9. Schultz I.J., Witjes J.A., Swinkels D.W., et al. Bladder cancer diagnosis and recurrence prognosis: comparison of markers with emphasis on surviving. Clin Chim Acta 368 (2006) 20
10. Vrooman O.P.J., and Witjes J.A. Urinary markers in bladder cancer. Eur Urol 50 (2008) 909
11. AJCC Cancer Staging Manual. 5th ed. (1997), Lippincott-Raven, Philadelphia 241
12. Sobin L.H., and Wittkind C. UICC TNM Classification of Malignant Tumors. 5th ed. (1997), Wiley Liss, New York 187
13. Papanicolaou G.N., and Marshall V.F. Urine sediment smears as a diagnostic procedure in cancers of the urinary tract. Science 101 (1945) 519
14. Eissa S., Swellam M., El-Mosallamy H., et al. Diagnostic value of urinary molecular markers in bladder cancer. Anticancer Res 23 (2003) 4347
15. Gui M., Idris M.A., Shi Y.E., et al. Reactivity of Schistosoma japonicum and S. mansoni antigen preparations in indirect haemagglutination (IHA) with sera of patients with homologous and heterogonous schistosomiasis. Ann Trop Med Parasitol 85 (1991) 599
16. Csoka A.B., Frost G.I., Wong T., et al. Purification and microsequencing of hyaluronidase isozymes from human urine. FEBS Lett 417 (1997) 307
17. Frost G., Coska T.B., Wong T., et al. Purification, cloning and expression of human plasma hyaluronidase. Biochem Biophys Res Commun 236 (1997) 10
18. Smith S.D., Wheeler M.A., Plescia J., et al. Urine detection of survivin and diagnosis of bladder cancer. JAMA 285 (2001) 324
19. Meadus W.J. A semi-quantitative RT-PCR method to measure the in vivo effect of dietary conjugated linoleic acid on porcine muscle PPAR gene expression. Biol Proced Online 5 (2003) 20
20. Moussa O., Abol-Enein H., Bissada N.K., et al. Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer. J Urol 175 (2006) 2312
21. Sun Y., He H., Ma Q., et al. Clinical evaluation of BTA stat, NMP22, HA, survivin, CD44v6, VEGF and VUC in bladder cancer diagnosis. Zhonghua Yi Xue Za Zhi 85 (2005) 2507
22. Fei Q., Zhang H., Fu L., et al. Experimental cancer gene therapy by multiple anti-survivin hammerhead ribozymes. Acta Biochim Biophys Sin 40 (2008) 466
23. Lokeshwar V.B., Schroeder G.L., Carey R.I., et al. Regulation of hyaluronidase activity by alternative mRNA splicing. J Biol Chem 277 (2002) 33654
24. Konety B.R. Molecular markers in bladder cancer: a critical appraisal. Urol Oncol Semin Orig Invest 24 (2006) 326